PRGO (Perrigo Co) Risk Assessment


PRGO Perrigo Co PLC PRGO
44 GF Score
Price $11.09
GF Value $24.97
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Perrigo Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Perrigo Co is: High Risk: High uncertainty.

Perrigo Co  (NYSE:PRGO) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Perrigo Co Risk Assessment Related Terms

PRGO vs XERS, PAHC, ALVO: Risk Assessment Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perrigo Co Risk Assessment vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Risk Assessment falls into.


PRGO
44GF Score
Perrigo Co PLC PRGO
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Perrigo Co (PRGO) Overvalued in 2026?

Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued. The current stock price of $11.09 is trading 55.6% below its estimated GF Value™ of $24.97. GuruFocus considers Perrigo Co to be Possible Value Trap.

Key valuation signals for PRGO:

  • Risk Assessment:
  • GF Value™: $24.97 vs. price of $11.09 (55.6% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the PRGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perrigo Co Business Description

Address The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score

Get the complete analysis for PRGO

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.09
Price
$24.97
GF Value